Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patientsUmberto Vitolo, L Resegotti, R Calvi et al.|Annals of Oncology|1998Cited by 93
Mantle Cell International Prognostic Index (MIPI) Is a Strong Predictor of the Outcome of Mantle Cell Lymphoma (MCL) in the Rituximab (R) Era.Annalisa Chiappella, Umberto Vitolo, Benedetta Puccini et al.|Blood|2009Cited by 4
THE ROLE OF MANTLE CELL INTERNATIONAL PROGNOSTIC INDEX (MIPI) AS SURVIVAL PREDICTOR IN MANTLE CELL LYMPHOMA (MCL) PATIENTS TREATED WITH RITUXIMAB AND CHEMOTHERAPYAnnalisa Chiappella, Umberto Vitolo, Benedetta Puccini et al.|Unknown|2010Cited by 0